This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4565839541 dexmethylphenidate ER 20 mg capsules, with a ceiling value of $1,719.48 and a performance period ending on September 18, 2024. The contract is not set-aside.
Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This delivery order contract is issued under that broader IDC, highlighting Dakota Drug, Inc.'s position as a key supplier for the DLA's military medical supply programs.
Generated 12/17/24, 9:02 AM